Compare DOMH & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DOMH | DRIO |
|---|---|---|
| Founded | 1967 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 53.1M | 56.8M |
| IPO Year | 2010 | 2013 |
| Metric | DOMH | DRIO |
|---|---|---|
| Price | $2.02 | $5.35 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $13.60 |
| AVG Volume (30 Days) | ★ 230.8K | 14.5K |
| Earning Date | 11-09-2026 | 11-12-2026 |
| Dividend Yield | ★ 47.42% | N/A |
| EPS Growth | 34.03 | ★ 1559.02 |
| EPS | N/A | ★ 1.75 |
| Revenue | ★ $123,104,000.00 | $7,394,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $38.77 |
| P/E Ratio | ★ N/A | $3.17 |
| Revenue Growth | ★ 578.41 | 43.02 |
| 52 Week Low | $1.91 | $5.18 |
| 52 Week High | $6.27 | $16.50 |
| Indicator | DOMH | DRIO |
|---|---|---|
| Relative Strength Index (RSI) | 39.84 | 34.69 |
| Support Level | $1.91 | N/A |
| Resistance Level | $3.33 | $8.01 |
| Average True Range (ATR) | 0.16 | 0.47 |
| MACD | -0.02 | -0.10 |
| Stochastic Oscillator | 6.48 | 7.85 |
Dominari Holdings Inc is a holding company that, through its various subsidiaries, is engaged in wealth management, investment banking, sales and trading, asset management, and insurance. In addition to capital investment, Dominari provides management support to the executive teams of its subsidiaries, helping them to operate efficiently and reduce costs under a streamlined infrastructure. The Company operates in two reportable business segments: Dominari Financial and Legacy AIkido, with the majority of revenue from Dominari Financial.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.